Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging paradigms and questions on pro-angiogenic bone marrow-derived myelomonocytic cells.

The International journal of developmental biology - 1 Jan 2011

Laurent Julien, Touvrey Cédric, Botta Francesca, Kuonen François, Ruegg Curzio

Abstract excerpt

Cancer-related inflammation has emerged in recent years as a major event contributing to tumor angiogenesis, tumor progression and metastasis formation. Bone marrow-derived and inflammatory cells promote tumor angiogenesis by providing endothelial progenitor cells that differentiate into mature endothelial cells, and by secreting pro-angiogenic factors and remodeling the extracellular matrix to stimulate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Bone Marrow Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoxia

Share to Inflammation

Share to Models, Biological

Share to Monocytes

Share to Neoplasms

Share to Neovascularization, Pathologic

Source

Identifiers

PMID: 21769777
DOI: 10.1387/ijdb.103228jl

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging paradigms and questions on pro-angiogenic bone marrow-derived myelomonocytic cells.PMID 21769777Read ↗

Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors.Semantic proximity Read ↗

Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progressionSemantic proximity Read ↗

The Endless Saga of Monocyte DiversitySemantic proximity Read ↗

Macrophages, Neutrophils, and Cancer: A Double Edged SwordSemantic proximity Read ↗

Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine systemSemantic proximity Read ↗

Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression.Semantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitorsSemantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

On the origin of myeloid-derived suppressor cells.Semantic proximity Read ↗

High-Dimensional Phenotyping of Human Myeloid-Derived Suppressor Cells/Tumor-Associated Macrophages in Tissue by Mass Cytometry.Semantic proximity Read ↗

N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.